| David Alcraft | Director |
Bridgehead International wins The Queen's Award for Enterprise (21 May 2007)
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade
New report from Pharmalicensing highlights the R&D opportunities in China (15 Jan 2007)
York, UK, 15 Jan 2006 - Pharmaceutical research and development in China is being constantly accelerated by successful clinical trials, a growing number of established R&D specialist companies and scientific technical expertise.
Pharmalicensing re-launches reports on the top 50 biopharmaceutical companies (6 Jun 2006)
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data
Bridgehead International publishes guide to pharma & biotech opportunities in India (15 May 2006)
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks
Pharmalicensing reports on five year therapy area-specific deals and alliances (27 Apr 2006)
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals
A globally recognized provider of consultancy, medical education and business information services to support extraordinary company and product growth in the healthcare sector.
Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain, through three divisions:
Bridgehead Consulting - international consultants in healthcare in areas of product strategy, business development, due diligence and valuation
Healthcare Education Services - specialists in the developments of global, regional and national integrated programs for the pharmaceutical industry in medical education, professional relations and medical communications
Pharmalicensing - the leading online business tool for biopharma dealmakers providing access to partner services, intelligence databases and business reports